Structural aspects of binding of α-linked digalactosides to human galectin-1
about
"Rules of Engagement" of Protein-Glycoconjugate Interactions: A Molecular View Achievable by using NMR Spectroscopy and Molecular ModelingRegression of fibrosis and reversal of cirrhosis in rats by galectin inhibitors in thioacetamide-induced liver diseaseUnderstanding the specificity of human Galectin-8C domain interactions with its glycan ligands based on molecular dynamics simulationsTherapy of experimental NASH and fibrosis with galectin inhibitors.Lactose binding to human galectin-7 (p53-induced gene 1) induces long-range effects through the protein resulting in increased dimer stability and evidence for positive cooperativity.The third dimension of reading the sugar code by lectins: design of glycoclusters with cyclic scaffolds as tools with the aim to define correlations between spatial presentation and activity.Galectin-3 inhibitors: a patent review (2008-present).Conformational selection in glycomimetics: human galectin-1 only recognizes syn-Ψ-type conformations of β-1,3-linked lactose and its C-glycosyl derivative.Microdomain Formation Controls Spatiotemporal Dynamics of Cell-Surface Glycoproteins.Close-up of the immunogenic α1,3-galactose epitope as defined by a monoclonal chimeric immunoglobulin E and human serum using saturation transfer difference (STD) NMRBinding of polysaccharides to human galectin-3 at a noncanonical site in its carbohydrate recognition domain.Structural significance of galectin design: impairment of homodimer stability by linker insertion and partial reversion by ligand presence.Defining the potential of aglycone modifications for affinity/selectivity enhancement against medically relevant lectins: synthesis, activity screening, and HSQC-based NMR analysis.Novel polysaccharide binding to the N-terminal tail of galectin-3 is likely modulated by proline isomerization.Dissecting the Structure-Activity Relationship of Galectin-Ligand Interactions.Galectins as Molecular Targets for Therapeutic Intervention.Differential recognition of Haemophilus influenzae whole bacterial cells and isolated lipooligosaccharides by galactose-specific lectins
P2860
Q26740050-7897306E-C42F-4A6B-95D6-1ABA451A4664Q28534290-DA998BEF-AC86-4C74-B083-46D5AC65C7E0Q34652147-114A6933-FAE9-4778-99FF-8116F0FDDB79Q35075568-A9C036EF-77D1-450F-9EAC-CEE23864A05EQ36716840-C8938C7B-BF27-4B67-AA42-52324CA186A2Q38096239-F78D2E2A-DB96-4475-846D-BBF5AE8138EDQ38238525-7B212125-AAB6-49F9-B996-C86E70EA7955Q38312051-941B0CD9-8BA8-42B2-814C-6BC44F7DE914Q38841912-3B6DBCC3-5579-4491-800E-B650C809391BQ39459595-E20FE731-D602-4B4B-BE68-2241B33F4069Q40232517-903CFE6B-6005-4A16-9C72-1F54E5197E42Q41183639-4DF183BD-9276-4A95-8700-BF2B4F34A984Q45988156-662D498A-8828-4DEF-92CD-0B716C4476B1Q46296067-DAFFFE43-80D4-409C-AC05-F7FDCBF80D49Q47547850-DA36112F-2240-4CDD-9B9A-0784404F2CB2Q55316400-21F50AB8-118F-4A99-A0DE-957A46BE5534Q58618241-C6A7AD79-0866-4422-B3EB-3026FD83C3F2
P2860
Structural aspects of binding of α-linked digalactosides to human galectin-1
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Structural aspects of binding of α-linked digalactosides to human galectin-1
@ast
Structural aspects of binding of α-linked digalactosides to human galectin-1
@en
type
label
Structural aspects of binding of α-linked digalactosides to human galectin-1
@ast
Structural aspects of binding of α-linked digalactosides to human galectin-1
@en
prefLabel
Structural aspects of binding of α-linked digalactosides to human galectin-1
@ast
Structural aspects of binding of α-linked digalactosides to human galectin-1
@en
P2093
P2860
P50
P356
P1433
P1476
Structural aspects of binding of α-linked digalactosides to human galectin-1
@en
P2093
Anatole A Klyosov
Kevin H Mayo
Linda G Baum
Mabel Pang
Virginia Roldós
P2860
P304
P356
10.1093/GLYCOB/CWR083
P50
P577
2011-06-28T00:00:00Z